HIGHLIGHTS
- who: Thomas Ripperda and colleagues from the Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center have published the research: Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses, in the Journal: Pharmaceuticals 2022, 15, 521. of March/21,/2022
- what: This study reports the design of novel antiviral peptides by developing an improved version of the database filtering technology , making peptide design more efficient. The study demonstrated that the designed peptides were inhibitory to the Ebola pseudo-virus in either prevention or treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.